Conducts analytical and clinical validation for immuno diagnostic assays such as lateral flow assay and cytopathology assay.Manages ethics-approved studies for clinical validation of medical device prototypes and assays.

• Analysed the efficacy of a novel prostate cancer screening assay with healthy and clinical samples. Created a metadata to analyse trends in quality of slides.• Conducted market research to analyse and predict the market for the novel screening test for men in China, Europe and South East Asia.• Co-created and coordinated an inventory management system for over 300 materials to ensure traceability as well as smooth production of COVID-19 diagnostic test kits.• Coordinated with Quality Assurance to co-create Inventory Management SOP and optimise Inspection, Identification and Traceability SOP for the company.

Project Title: Role of Gut Microbiome in Extra-hepatic Metabolism of Antimalarial Drugs• Created and optimised protocols to investigate the effects of gut microbiome activity on a potential antimalarial compound series with in vitro Drug Metabolism and Pharmacokinetics (DMPK) Scientist Dr Ola Epemolu. • Discovered that the low bioavailability of the antimalarial compounds were due to anaerobic enzymatic activity by gut microbiome.• Co-crafted Assay Development and Screening proposals as a DMPK Scientist as part of a Drug Discovery project to virtually screen 8841 compounds on Vortex software against Visceral Leishmaniasis.